dipyridamole has been researched along with Weight Gain in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, C | 1 |
| Schwab, LP | 1 |
| Fan, M | 1 |
| Seagroves, TN | 1 |
| Buolamwini, JK | 1 |
1 other study available for dipyridamole and Weight Gain
| Article | Year |
|---|---|
Chemoprevention activity of dipyridamole in the MMTV-PyMT transgenic mouse model of breast cancer.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Dipyridamole; Disease | 2013 |